Cancer

RSS

Exclusive worldwide rights offered for human full-length TRK-B

Nov. 28, 1996

Natural farnesyltransferase inhibitors from Kitasato Institute

Nov. 28, 1996

New taxane derivatives from Rhone-Poulenc Rorer

Nov. 27, 1996

Protegrin development candidate selected by IntraBiotics

Nov. 26, 1996

Human brain-derived protein kinase offered for licensing

Nov. 26, 1996

Interim clinical results with Ansan's cancer product

Nov. 22, 1996

New target for drug-resistant tumors identified

Nov. 22, 1996

Mercian discloses novel mitomycin

Nov. 22, 1996

Antitumor lactam isolated by Japanese researchers

Nov. 22, 1996

Vion Pharmaceuticals expands pivotal trials of new cancer treatment

Nov. 21, 1996